In a significant advancement, a modified darobactin compound has shown promise in treating drug-resistant bacterial infections in animal models, offering a potential new weapon against pathogens like E. coli that increasingly evade current antibiotics. Antibacterial drugs are essential for treating infections, but the growing problem of bacterial resistance has rendered many current treatments less effective […]
Leave a comment
You must be logged in to post a comment.